T1	Outcomes 639 679	the frequency of serious adverse events.
T2	Outcomes 680 742	Peripheral blood counts, CD34(+) count, and functional outcome
T3	Outcomes 762 841	assessed lesion volume, atrophy, and the presence of iron-labeled CD34(+) cells
T4	Outcomes 901 918	at mean of 8 days
T5	Outcomes 1149 1183	with serious adverse events: G-CSF
T6	Outcomes 1227 1250	20, death or dependency
T7	Outcomes 1325 1362	or the number of injections received.
T8	Outcomes 1363 1414	G-CSF increased CD34(+) and total white cell counts
T9	Outcomes 1476 1515	reduction in MRI ischemic lesion volume
T10	Outcomes 1633 1654	labeled CD34(+) cells
